ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 124 • 2018 ACR/ARHP Annual Meeting

    M10, a Small Fragment of the Hepatocyte Growth Factor Receptor, Attenuates Fibrotic Changes in a Murine Model of Scleroderma Lung Disease and in Human Lung Fibroblasts

    Tanjina Akter1, Ilia Atanelishvili1, Atsushi Noguchi2, Galina S. Bogatkevich1 and Rick Silver3, 1Division of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, Charleston, SC, 2Division of Rheumatology, Endocrinology and Nephrology,, Hokkaido University Graduate School of Medicine, Sapporo, Japan, 3Rheumatology, Medical University of SC, Charleston, SC

    Background/Purpose: Interstitial lung disease (ILD) is the major cause of mortality among scleroderma (systemic sclerosis, SSc) patients. Extracellular matrix (ECM) deposition is a hallmark of…
  • Abstract Number: 125 • 2018 ACR/ARHP Annual Meeting

    Monocyte Transcriptome Delineates SSc Patients with Functionally Distinct Patterns of Gene Dysregulation That Persist through Differentiation

    Julia L.M. Dunn1, Philip J. Homan2, Salina Dominguez1, Carla M. Cuda1, Kathleen Aren3, Mary A. Carns3,4, Tracy M. Frech5, Dinesh Khanna6, Shervin Assassi7, Harris Perlman1, Monique Hinchcliff1 and Deborah R. Winter1, 1Department of Medicine Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, 2Division of Rheumatology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, 3Northwestern University, Feinberg School of Medicine Scleroderma Program, Chicago, IL, 4Department of Medicine, Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, 5Division of Rheumatology, University of Utah, Salt Lake City, UT, 6Division of Rheumatology, University of Michigan, Ann Arbor, MI, 7Rheumatology, University of Texas Health Science Center at Houston, Houston, TX

    Background/Purpose: The etiology and pathogenesis of SSc are poorly understood; however, an increasing body of evidence supports an early inflammatory phase that precedes, and may…
  • Abstract Number: 126 • 2018 ACR/ARHP Annual Meeting

    Direct Interaction between Autoreactive B Cells and Endothelial Colony Forming Cells Induces Cytokine Production from B Cells through B Cell Receptor and IL-6-JAK2-STAT3 Signaling Pathway, Suppressing Proliferation of Endothelial Colony Forming Cells in Systemic Sclerosis

    Takemichi Fukasawa1, Ayumi Yoshizaki1, Satoshi Ebata1, Kouki Nakamura1, Yoshihide Asano1, Yutaka Kazoe2, Kazuma Mawatari2, Takehiko Kitamori2 and Shinichi Sato1, 1Department of Dermatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan, 2Department of Applied Chemistry, Graduate School of Engineering, The University of Tokyo, Tokyo, Japan

    Background/Purpose: Systemic sclerosis (SSc) is a connective tissue disorder that is characterized by fibrosis and vascular damage in the skin and other visceral organs, with…
  • Abstract Number: 127 • 2018 ACR/ARHP Annual Meeting

    MiR-3606-3p Inhibits Systemic Sclerosis through Targeting TGF-β Receptor II

    Xiangguang Shi1, Qingmei Liu2, Wenzhen Tu3, Xueqian Mei1, Li Jin4, Wenyu Wu5 and Jiucun Wang4, 1State Key Laboratory of Genetic Engineering, Department of Anthropology and Human Genetics, School of Life Sciences, Fudan University, Shanghai, China, 2State Key Laboratory of Genetic Engineering and Ministry of Education Key Laboratory of Contemporary Anthropology, Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Fudan University, Shanghai, Chile, 3Medicine, Shanghai Traditional Chinese Medicine-Integrated Hospital, Shang hai, China, 4State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Fudan University, Shanghai, China, 5Department of Dermatology, Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China, Shanghai, China

    Background/Purpose: Though transforming growth factor-b (TGF-b) plays a fundamental role in the pathogenesis of SSc, the mechanism by which TGF-b signaling acts in SSc remains…
  • Abstract Number: 128 • 2018 ACR/ARHP Annual Meeting

    Inhibition of Prolyl-tRNA Synthetase As a Novel Therapeutic Target for Systemic Sclerosis

    Caroline H. Lee1, Seong-Jin Yoon1, Minjae Cho1, Joon Seok Park2, Yena Kim3, Ji Hyeon Ju4, Da-Jeong Bae5, Choon-Sik Park5, Jong Hyun Kim6, Sunghoon Kim6 and Bongyong Lee1, 1Daewoong Pharmaceuticals, Seoul, Korea, Republic of (South), 2Daewoong pharmaceutical, Seoul, Korea, Republic of (South), 3Catholic iPSC Research Center, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South), 4Division of Rheumatology, Department of Internal Medicine,, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South), 5Division of Allergy and Respiratory Medicine, Soonchunhyang University Bucheon Hospital, Seoul, Korea, Republic of (South), 6Medicinal Bioconvergence Research Center, Seoul National University, Seoul, Korea, Republic of (South)

    Background/Purpose: Prolyl-tRNA synthetase (PRS), a member of aminoacyl tRNA synthetases (ARS), is an enzyme that conjugates amino acid proline to its tRNA to generate prolyl-tRNA…
  • Abstract Number: 129 • 2018 ACR/ARHP Annual Meeting

    Rnaseq Analysis of Human Skin in Organ Culture Identifies Collagen 22A1 As a TGF-β Early Response Gene

    Tomoya Watanabe1, Logan Mlakar2, Jonathan Heywood3, Willian da Silveira4, Gary Hardiman5 and Carol A. Feghali-Bostwick6, 1Rheumatology, Medical University of South Carolina, Charleston, SC, 2Medical University of South Carolina, Charleston, SC, 3Rheumataology, Medical University of South Carolina, Chareston, SC, 4Center for Genomic Medicine, Medical University of South Carolina, Charleston, SC, 5Department of Medicine, Medical University of South Carolina, Charleston, SC, 6Department of Medicine, Medical University of South Carolina, Division of Rheumatology and Immunology, Charleston, SC

    Background/Purpose: Systemic sclerosis (SSc) is a complex multi-system autoimmune disease characterized by immune dysregulation, vasculopathy, and organ fibrosis. Skin fibrosis causes high morbidity and impaired…
  • Abstract Number: 130 • 2018 ACR/ARHP Annual Meeting

    The Role of Cofilin, an Actin Associated Protein, in Activation of Systemic Sclerosis Vascular Smooth Muscle Cells

    Shadia Nada, Bashar Kahaleh and Nezam Altorok, Medicine/Rheumatology, University of Toledo, Toledo, OH

    Background/Purpose: Systemic sclerosis (SSc) is an autoimmune connective tissue disease characterized by activation of the immune system, vascular dysfunction and tissue fibrosis. Vascular dysfunction in…
  • Abstract Number: 131 • 2018 ACR/ARHP Annual Meeting

    Myofibroblast Cells Expression of CD248 May Contribute to Exacerbate Microvascular Damage during Systemic Sclerosis

    Paola Di Benedetto1, Rebecca Ross2, Paola Cipriani1, Filomena Esteves3, Vasiliki Liakouli1, Piero Ruscitti1, Francesco Carubbi1, Onorina Berardicurti1, Noemi Panzera1, Salvatore Di Bartolomeo1, Chiara Galloni4, Georgia Mavria4, Francesco Del Galdo2 and Roberto Giacomelli1, 1Department of Applied Clinical Sciences and Biotechnology, Rheumatology Unit, University of L'Aquila, L'Aquila, Italy, 2Leeds Biomedical Research Centre and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 3Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, United Kingdom, 4Signal Transduction and Tumour Microenvironment Group, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, Italy

    Background/Purpose: Microvascular rarefaction and tissue fibrosis are the hallmarks of Systemic Sclerosis (SSc). CD248, also known as endosialin, is a transmembrane glycoprotein expressed on key…
  • Abstract Number: 132 • 2018 ACR/ARHP Annual Meeting

    Novel Therapeutic Peptides Which Target CD206 Inhibit Macrophage Dependent Fibroblast Activation in Scleroderma

    Bahja Ahmed Abdi1, Henry Lopez2, George Martin3, Charles Garvin3, Jesse Jaynes3, James Stanway4, Christopher P. Denton5, David Abraham6, Shivanee Vigneswaran7, Sian Morris7 and Richard J Stratton8, 1Division of Medicine, Centre for Rheumatology and Connective Tissue Diseases, University College London, London, United Kingdom, 2Murigenics, Vallejo, CA, 3Riptide Bioscience, Vallejo, CA, 4Centre for Rheumatology and Connective Tissue diseases, University College London, London, United Kingdom, 5UCL Division of Medicine, Royal Free Campus, London, United Kingdom, 6Division of Medicine, Centre for Rheumatology and Connective Tissue Disease, University College London, London, United Kingdom, 7Centre for Rheumatology and Connective Tissue Diseases, University College London, London, United Kingdom, 8Centre for Rheumatology and Connective Tissue Disease, University College London, London, United Kingdom

    Background/Purpose: Alternatively activated macrophages expressing CD206 are believed to promote fibrosis in a range of disorders including systemic sclerosis (SSc). Novel therapeutic peptides (RP) which…
  • Abstract Number: 133 • 2018 ACR/ARHP Annual Meeting

    GBR830, a True OX40 Antagonist Antibody with Potent Suppressive Effects on T Cell-Mediated Pathological Responses

    Julie Macoin1, Stanislas Blein1, Thierry Monney1, Pavankumar Sancheti2, Venkateshwar Reddy3 and Jonathan Back1, 1Glenmark Pharmaceuticals SA, La Chaux-de-Fonds, Switzerland, 2Glenmark Pharmaceuticals Ltd, Mumbai, India, 3Glenmark Pharmaceuticals SA, Paramus, NJ

    Background/Purpose: OX40 (TNFRSF4, CD134) is a costimulatory receptor member of the NGFR/TNFR superfamily expressed predominantly on activated T lymphocytes. Ligation of OX40 by its ligand…
  • Abstract Number: 134 • 2018 ACR/ARHP Annual Meeting

    Exploration of T-Cell Signatures Following TCR Stimulation Using Single Cell RNA-Seq to Inform Treatment Response Studies in Rheumatoid Arthritis

    Paul Martin1, James Ding1, Ben Mulhearn1, Sebastien Viatte1 and Stephen Eyre1,2, 1Arthritis Research UK Centre for Genetics and Genomics, Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University of Manchester, Manchester, United Kingdom, 2NIHR Manchester Musculoskeletal Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester, United Kingdom

    Background/Purpose: For rheumatoid arthritis (RA), as with many other rheumatic diseases, the importance of determining which therapy will work best, early in disease, to prevent…
  • Abstract Number: 135 • 2018 ACR/ARHP Annual Meeting

    High Dimensional Analysis By Mass Cytometry and RNA-Sequencing Reveals Altered Frequency and Exhausted Features of CD4 T and MAIT Cells in Systemic Sclerosis

    Bhairav Paleja1, Andrea Hsiu Ling Low2, Pavanish Kumar1, Suzan Saidin1, Ahmad Lajam2, Camillus Chua3, Liyun Lai1 and Salvatore Albani4, 1Translational Immunology Institute, Singhealth/Duke-NUS Academic Medical Centre, Singapore, Singapore, 2Singapore General Hospital, Singapore, Singapore, 3Translational Immunology Institute, Singhealth/Duke-NUS Academic Medical Centre, Singapore Health Services Pte Ltd, Singapore, Singapore, 4Translational Immunology Institute, Singhealth/Duke-NUS Acedemic Medical Centre, Singapore, Singapore

    Background/Purpose: Systemic sclerosis (SSc) is an autoimmune disease characterised by excessive fibrosis of skin and internal organs, and vascular dysfunction. Association of T and B…
  • Abstract Number: 136 • 2018 ACR/ARHP Annual Meeting

    Alpn-101, a Dual ICOS/CD28 Antagonist, Potently Suppresses Disease in Multiple Mouse Models of Autoimmunity

    Stacey Dillon1, Katherine Lewis1, Lawrence Evans2, Ryan Swanson2, Jing Yang3, Martin Wolfson4, Michelle Seaberg1, Kayla Susmilch5, Sherri Mudri1, Mark Rixon4, Stanford Peng6 and Kristine Swiderek7, 1Translational Sciences, Alpine Immune Sciences, Seattle, WA, 2Immunology, Alpine Immune Sciences, Seattle, WA, 3Clinical, R&D, Alpine Immune Sciences, SEATTLE, WA, 4Protein Therapeutics, Alpine Immune Sciences, Seattle, WA, 5Translational Sciences, Alpine Immune Sciences, SEATTLE, WA, 6Clinical, R&D, Alpine Immune Sciences, Seattle, WA, 7Research, Alpine Immune Sciences, SEATTLE, WA

    Background/Purpose: CD28 and Inducible T-cell Costimulator (ICOS) are two related costimulatory molecules within the immunoglobulin superfamily (IgSF) expressed on T cells and interacting with CD80/CD86…
  • Abstract Number: 137 • 2018 ACR/ARHP Annual Meeting

    Autoantibody-Inducing CD4 T (aiCD4 T) Cells Which Induce Systemic Lupus Erythematosus (SLE) Contain Follicular Helper T Cell in Addition to the Major IL-21-Producing CXCR5-ICOShiPD1hi Population: Self-Organized Criticality Theory As the Cause of SLE

    Ken Tsumiyama and Shunichi Shiozawa, Institute for Rheumatic Diseases, Nagahama, Japan

    Background/Purpose: We have shown that repeated immunization with antigen induces systemic lupus erythematosus (SLE) in the mice otherwise not prone to spontaneous autoimmune diseases. We…
  • Abstract Number: 138 • 2018 ACR/ARHP Annual Meeting

    Distinct Roles of Tfh2, SLAMF7+ Tfh1 Cells and Th1 Cells in the Pathogenesis of IgG4-RD

    Kazuhiko Higashioka1, Masahiro Ayano1, Yasutaka Kimoto2, Hiroki Mitoma1, Mitsuteru Akahoshi1, Yojiro Arinobu1, Koichi Akashi1, Takahiko Horiuchi3 and Hiroaki Niro4, 1Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan, 2Department of Internal Medicine, Kyushu University Beppu Hospital, Oita, Japan, 3Department of Internal Medicine, Kyushu University Beppu Hospital, Beppu, Japan, 4Department of Medical Education, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan

    Background/Purpose: IgG4-related disease (IgG4-RD) is a novel disease entity characterized by the infiltration of IgG4-secreting plasmablasts (PBs) and the generation of germinal centers in various…
  • « Previous Page
  • 1
  • …
  • 1011
  • 1012
  • 1013
  • 1014
  • 1015
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology